(Q40793195)

English

Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

author name string

Essey RJ

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

McDougall BR

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Robinson WE Jr

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

189-202

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-Hiv-1 Activity of 2',3'-Dideoxinucleoside Analogues : Structure-Activity Relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mismatched dsRNA (ampligen) induces protection against genomic variants of the human immunodeficiency virus type 1 (HIV-1) in a multiplicity of target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of HIV-1 proviral DNA synthesis and RNA accumulation by mismatched dsRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategic design and three-dimensional analysis of antiviral drug combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational design of peptide-based HIV proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mode of action of the anti-AIDS compound poly(I).poly(C12U) (Ampligen): activator of 2',5'-oligoadenylate synthetase and double-stranded RNA-dependent kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900150-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(01)00150-4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40793195&oldid=1907418685"